Press Room - Sanofi US News

Media Room Menu

Month Year

Jun 4, 2021

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

* Sanofi partnering with the Breast International Group (BIG), the European Organization for Research and Treatment of Cancer (EORTC) and Alliance Foundation Trials (AFT), which are world-leading academic groups delivering practice-changing breast cancer clinical research
Jun 2, 2021

Provention Bio Announces the Grant of Inducement Awards
Jun 1, 2021

Provention Bio to Present at the Jefferies Virtual Healthcare Conference
Jun 1, 2021

Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States

* This combination vaccine may simplify execution and reduce shots needed to complete CDC's recommended child and adolescent immunization schedule
May 27, 2021

FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D)

If approved, teplizumab will be the first disease-modifying therapy in T1D

Show per page